tirzepatide cardiovascular In patients with type 2 diabetes and atherosclerotic disease, was noninferior to dulaglutide with respect to major cardiovascular events. ⁣, ⁣, Read the full SURPASS-CVOT Tirzepatide Matches Competitor's Cardioprotective Benefits

One such treatment option is the use of GLP-1 agonist drugs, which have been shown to be effective in promoting weight loss

Clinicians are nonetheless advised to monitor patients on any hormonal therapy when initiating weight-loss treatments, given the potential for significant physiological changes with substantial weight loss

Stay ahead of the crash

Compounded medications are prepared by specialized pharmacies and are not FDA-approved, though they may be prescribed when appropriate

This segment accounts for over 61% of the market, with ongoing innovation aimed at refining treatments to secure favorable formulary tier placement and maintain a leading position in patient care

By delaying gastric emptying, semaglutide may alter the rate and extent of absorption of orally administered medications, particularly those requiring rapid absorption for optimal effect or those with a narrow therapeutic window